Picture of Kenvue logo

KVUE — Kenvue News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesBalancedLarge CapSuper Stock

Okta reverses course; cybersecurity co poised to replace Tylenol maker Kenvue in S&P 500

    (Updates, adds context)
    ** Shares of digital identity verification co Okta  OKTA.O 
surrender premarket gains, and last down 5.2% to $197.44 on Mon
as it's set to join S&P 500 index  .SPX  this week
    ** OKTA migrating from S&P MidCap 400  .IDX  to replace
Kenvue  KVUE.N  in SPX effective Weds, Nov 4, S&P Dow Jones
Indices announced late Fri
    ** Kimberly-Clark  KMB.O  is acquiring Tylenol maker KVUE in
roughly $40 bln deal expected to close soon
    ** OKTA's stock and those of cybersecurity peers, including
CrowdStrike  CRWD.O  and Zscaler  ZS.O , adding to recent losses
on Mon after Fortinet  FTNT.O  last week flagged slower growth
    ** On Mon, Israel-based Check Point Software Technologies'
 CHKP.O  shares sliding 4% after cybersecurity firm trims 2026
estimates
    ** Passive funds will need to purchase ~9.5 mln OKTA shares,
implying 3 days of buying demand, Stephens analyst Melissa
Roberts outlined in note to clients
    ** San Francisco, California-based OKTA has ~174.8 mln
shares outstanding for about $36.4 bln market cap as of Fri
    ** Despite the decline, OKTA stock up ~128% YTD
    ** 36 of 45 analysts rate the stock "strong buy" or "buy", 9
"hold"; median PT $225, per LSEG data
    ** In turn, medtech co Glaukos  GKOS.N  moving from S&P
SmallCap 600  .SPCY  to replace OKTA in the IDX, while
business-to-business rental firm McGrath RentCorp  MGRC.O  to
enter the SPCY on Weds

    (Lance Tupper is a Reuters market analyst. The views
expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))

Recent news on Kenvue

See all news